Cargando…
Myeloid sarcoma of the pancreas: A case report and literature review
INTRODUCTION: Myeloid sarcoma (MS) is an extramedullary mass, consisting of myeloid blasts with or without maturation, which efface the normal tissue architecture. It occurs mainly in lymph nodes, skin and soft tissue, testis, bone, peritoneum, and gastrointestinal tract, but rarely in the pancreas....
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021285/ https://www.ncbi.nlm.nih.gov/pubmed/33787578 http://dx.doi.org/10.1097/MD.0000000000024913 |
_version_ | 1783674721105084416 |
---|---|
author | Wu, Kangze Zhang, Xuzhao Zhang, Bo |
author_facet | Wu, Kangze Zhang, Xuzhao Zhang, Bo |
author_sort | Wu, Kangze |
collection | PubMed |
description | INTRODUCTION: Myeloid sarcoma (MS) is an extramedullary mass, consisting of myeloid blasts with or without maturation, which efface the normal tissue architecture. It occurs mainly in lymph nodes, skin and soft tissue, testis, bone, peritoneum, and gastrointestinal tract, but rarely in the pancreas. Because their clinical courses, treatments, and prognoses are quite different, it is crucially important to distinguish between MS and pancreatic cancer. PATIENT CONCERNS: We herein report a rare case of acute myeloid leukemia (AML) which presented with a pancreatic mass that mimicked pancreatic cancer. Diagnosis: The diagnosis of MS was established based on immunohistochemical (IHC) analysis and bone marrow examination which revealed neoplastic cells with CD34+/CD117+. INTERVENTIONS: The patient was actively treated with chemotherapy. OUTCOMES: After 4 cycles of chemotherapy, the lesion in pancreas was significantly reduced, and the patient is still receiving further chemotherapy. CONCLUSION: When we encounter a patient suspected of pancreatic cancer with blood cell abnormalities and no significant increase in carbohydrate antigen 19-9 (CA19-9), we need to be aware of the possibility of pancreatic MS. Preoperative pathological biopsy and IHC are indispensable. Misdiagnosis is common if we rely solely on imaging. |
format | Online Article Text |
id | pubmed-8021285 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-80212852021-04-07 Myeloid sarcoma of the pancreas: A case report and literature review Wu, Kangze Zhang, Xuzhao Zhang, Bo Medicine (Baltimore) 5700 INTRODUCTION: Myeloid sarcoma (MS) is an extramedullary mass, consisting of myeloid blasts with or without maturation, which efface the normal tissue architecture. It occurs mainly in lymph nodes, skin and soft tissue, testis, bone, peritoneum, and gastrointestinal tract, but rarely in the pancreas. Because their clinical courses, treatments, and prognoses are quite different, it is crucially important to distinguish between MS and pancreatic cancer. PATIENT CONCERNS: We herein report a rare case of acute myeloid leukemia (AML) which presented with a pancreatic mass that mimicked pancreatic cancer. Diagnosis: The diagnosis of MS was established based on immunohistochemical (IHC) analysis and bone marrow examination which revealed neoplastic cells with CD34+/CD117+. INTERVENTIONS: The patient was actively treated with chemotherapy. OUTCOMES: After 4 cycles of chemotherapy, the lesion in pancreas was significantly reduced, and the patient is still receiving further chemotherapy. CONCLUSION: When we encounter a patient suspected of pancreatic cancer with blood cell abnormalities and no significant increase in carbohydrate antigen 19-9 (CA19-9), we need to be aware of the possibility of pancreatic MS. Preoperative pathological biopsy and IHC are indispensable. Misdiagnosis is common if we rely solely on imaging. Lippincott Williams & Wilkins 2021-04-02 /pmc/articles/PMC8021285/ /pubmed/33787578 http://dx.doi.org/10.1097/MD.0000000000024913 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 5700 Wu, Kangze Zhang, Xuzhao Zhang, Bo Myeloid sarcoma of the pancreas: A case report and literature review |
title | Myeloid sarcoma of the pancreas: A case report and literature review |
title_full | Myeloid sarcoma of the pancreas: A case report and literature review |
title_fullStr | Myeloid sarcoma of the pancreas: A case report and literature review |
title_full_unstemmed | Myeloid sarcoma of the pancreas: A case report and literature review |
title_short | Myeloid sarcoma of the pancreas: A case report and literature review |
title_sort | myeloid sarcoma of the pancreas: a case report and literature review |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021285/ https://www.ncbi.nlm.nih.gov/pubmed/33787578 http://dx.doi.org/10.1097/MD.0000000000024913 |
work_keys_str_mv | AT wukangze myeloidsarcomaofthepancreasacasereportandliteraturereview AT zhangxuzhao myeloidsarcomaofthepancreasacasereportandliteraturereview AT zhangbo myeloidsarcomaofthepancreasacasereportandliteraturereview |